Antidote.me

by Antidote Technologies, Inc.  · Based in United States → — Where patients meet research
Cardiology Neurology Oncology
Website
Claim this tool
Is this the maker? Claim the company →

Contact for pricing (enterprise-level, calibration model, pay-for-performance)
Regulatory Status Disclosed

Overview

Antidote.me, by Antidote Technologies, Inc., is a medical AI tool focused on accelerating clinical trial patient recruitment. It addresses the challenge of over 80% of medical research being delayed due to insufficient participants.

The platform is primarily for clinical trial sponsors, researchers, and healthcare providers involved in medical research. It aims to bridge the gap between patients and research by making clinical trials more accessible.

Antidote.me integrates into the clinical workflow by offering a smart search engine, Antidote Match, which uses AI and structured data to determine patient eligibility for clinical trials. It collects clinical study information from sources like the WHO and ClinicalTrials.gov, translating it into machine-readable structured data. Patients can use the tool to find trials by answering questions about their medical history and demographics, while sponsors benefit from precision recruitment services.

Notable capabilities include its AI-powered matching engine that considers inclusion and exclusion criteria, patient location, and willingness to travel. Antidote also offers services like validated referrals, customized outreach plans, and access to a network of over 300 nonprofit and patient advocacy partners. The platform emphasizes patient-centric communication and user-friendly search tools to improve engagement and retention in clinical trials.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Precision recruitment for clinical trials
  • AI-powered Smart Match search engine for patients
  • Connects patients and researchers to accelerate medical research
  • Leverages medical ontologies for accurate matching
  • Integrates data from ClinicalTrials.gov and WHO
  • Utilizes data-driven technologies and digital expertise
  • Extensive partner network including hundreds of health nonprofits and patient advocates
  • Site follow-up services to close the loop on recruitment
  • Complete engagement tracking and optimization for sponsors
  • Risk-sharing payment model for sponsors

Use Cases

  • Accelerating clinical trial patient recruitment for sponsors
  • Enabling patients to easily find suitable clinical trials
  • Improving patient engagement in clinical research
  • Optimizing trial design and site selection (future product)
  • Supporting diversity, equity, and inclusion in clinical trials

What Physicians Need to Know

Clinical Trial Matching
Antidote's core offering is 'Antidote Match,' a smart clinical trial matching tool. It leverages structured data, proprietary algorithms, and AI to connect patients with suitable clinical trials by matching their medical history and demographics against complex inclusion and exclusion criteria from ClinicalTrials.gov.
Real-World Evidence Analysis
While not a direct RWE analysis tool, Antidote's partnership with SEQSTER enables the aggregation of disparate health data sources, including EHRs, for a 360-degree view of a patient in real-time. This supports enhanced patient identification and enrollment, and can contribute to datasets used for real-world evidence.
Genomic Data Integration
Through its partnership with SEQSTER, Antidote can integrate genomic DNA data, alongside other health data like EHRs and wearables, to create a comprehensive patient profile. This integration enhances the precision of patient matching for clinical trials.
Collaboration Features
Antidote extensively partners with over 300 nonprofits, patient advocacy groups, publishers, and healthcare leaders to broaden its reach and provide dynamic content for their communities. They also offer 'Enterprise Match' as a SaaS solution, allowing sponsors to host a customized trial search directly on their websites.
Physician Tip

Physicians can utilize Antidote.me as a valuable resource to help patients identify relevant clinical trial opportunities. The platform simplifies the often complex information found on ClinicalTrials.gov, making it easier for both physicians and patients to navigate and understand eligibility criteria. Discussing Antidote.me with patients can empower them to explore new treatment options and contribute to medical research, especially since many patients prefer to learn about trials from their trusted healthcare providers.

Antidote.me integrates directly with ClinicalTrials.gov to source trial listings. A significant integration is with SEQSTER, which allows for the aggregation of various health data sources, including EHRs, genomic DNA, wearables, and pharmacy data, to enhance patient identification and enrollment for clinical trials. Antidote also offers white-label solutions, enabling sponsors to embed the clinical trial matching tool directly into their own websites.

Details

Category Drug Discovery & Research
Pricing Contact for pricing (enterprise-level, calibration model, pay-for-performance)
  • Offers a calibration model with an upfront flat fee to determine per-patient recruitment cost, followed by a pay-for-performance contract, aiming for cost savings for sponsors
DeploymentCloud-based (SaaS)
Compliance
BAA Available Yes AI-estimated
HIPAA Compliant Yes AI-estimated
FDA Status Not applicable AI-estimated
Integrations
EHR Not specified
Specialties Cardiology, Neurology, Oncology

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Antidote.me

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for Antidote.me.

View all on YouTube

Frequently Asked Questions

Antidote.me primarily serves as a patient recruitment platform that connects patients with clinical trials through a smart matching engine and AI, which processes trial information from sources like ClinicalTrials.gov. Physicians can direct their patients to Antidote's platform, where patients answer questions about their medical history to be matched with relevant studies based on inclusion and exclusion criteria. This streamlines the process of identifying potential research opportunities for patients.
Antidote.me has a dedicated compliance department and has achieved high scores in cybersecurity risk assessments, particularly a 100% score in privacy. They are committed to governing and managing data in accordance with applicable regulations and industry best practices. This includes robust privacy policies, incident reporting, security audits, and training to protect sensitive patient and client data.
Antidote.me utilizes a multi-faceted digital recruitment strategy, including digital advertising, patient databases, and a network of over 270 health nonprofit and patient advocacy partners. This approach aims to reach a broader and more diverse patient population efficiently, often proving more effective and cost-saving than traditional methods. While other digital services exist, Antidote emphasizes its AI-powered matching and partner network for precision recruitment.
While specific pricing details are not publicly disclosed, clinical trial recruitment companies like Antidote.me typically offer various budget models, such as paying for performance or negotiating a flat fee. Patient recruitment can account for a significant portion, up to 40%, of a trial's total budget, and delays due to recruitment issues can incur substantial daily costs for sponsors.
Physicians might face challenges related to patient awareness and willingness to participate, as many patients prefer to hear about trials directly from their doctors rather than online ads. Although Antidote aims to improve patient engagement, logistical barriers for patients, such as time commitment or travel, can still impact enrollment. Additionally, the complexity of eligibility criteria can lead to screen failures, despite Antidote's matching technology.
Antidote.me's services include EHR matching as a method for clinical trial recruitment, which allows for targeting patients based on specific eligibility criteria within their health records. However, the non-standardized nature of EHR technology across different vendors can make integrations challenging. Despite this, EHR matching is considered a powerful tool for reaching patients who prefer to learn about trials from their doctors.
Antidote.me prescreens patients before referring them to research companies, aiming to target only eligible individuals and optimize the use of time and resources. They track and optimize patient engagement throughout the process. Furthermore, patients introduced to a study through Antidote's partner network of health organizations often exhibit higher engagement due to a more trusting relationship.

Related Tools

MyTrials.ai
MyTrials.ai
Drug Discovery & Research
MyTrials.ai is an AI-powered platform for clinical trial recruitment, combining a verified patient network, intelligent matching, and human navigators to accelerate enrollment.
HypeCheck
2 Minute Medicine
Clinical Decision Support & Reference
HypeCheck™ instantly evaluates health articles, wellness advice, and viral trends by cross-referencing them directly against peer-reviewed literature on PubMed, active clinical trials, and official health agency guidance.
$4.99/month or $49.90/year
Scite
Scite
Drug Discovery & Research
Scite is an AI research tool that shows how papers have been cited, providing context on whether findings are supported or contradicted by subsequent research, which is valuable for medical writers and researchers.
Tiered pricing model with free, basic, premium, premium+, group, and enterprise plans.
Google Bard
Google
Clinical Decision Support & Reference
Google Bard, now known as Gemini, is a generative AI model that can assist healthcare professionals with tasks such as summarizing medical records and research papers, generating hypotheses, and providing information on medical conditions.
Freemium
AIDDISON Explorer
Sigma-Aldrich (Merck KGaA)
Drug Discovery & Research
AIDDISSON Explorer is an AI-powered drug discovery platform combining generative AI with computer-aided drug design for molecular generation, virtual screening, ADMET prediction, and retrosynthesis planning.
Noodle Biomedical Literature Discovery
Helena Bioinformatics
Drug Discovery & Research
Noodle is a biomedical literature discovery platform that allows researchers to search publications by meaning, inspect paper details, and explore related evidence through citation connections and semantic neighborhoods. It offers a public read-only Model Context Protocol (MCP) interface for AI agents.
Free

See all Drug Discovery & Research tools →

Suggest an Edit → | Last Verified: 2026-04-24 | First Added: 2026-04-24
AI Tool Finder
AI-powered search. Results may not be comprehensive.